---
author: Harvey Guo
created: 2024-03-15 13:47
modified: 2024-03-15 13:47
aliases:
  - Antipsychotic
share: true
---
>[!Mnemonic] 
>Antipsychotics are thought to work by blocking the <font color="#ffc000">D2</font> receptor.
>Psychotic patients sometimes take a <font color="#ffc000">DetouR</font> from reality.![[../../assets/img/Pasted image 20240315135310.png|Pasted image 20240315135310.png]]


- First-generation antipsychotics (also called typical antipsychotics): block D2 receptor → ↑ cAMP
	- High-potency antipsychotics have a strong antipsychotic effect even at relatively low doses, but they also more commonly cause neurologic side effects (e.g., extrapyramidal symptoms) than low-potency antipsychotics.
		- <span style="background:rgba(240, 200, 0, 0.2)">Haloperidol</span>
		- <span style="background:rgba(240, 200, 0, 0.2)">Fluphenazine</span>
		- Perphenazine
		- Trifluoperazine
		- Pimozide
	- Low-potency antipsychotics more commonly cause anticholinergic, [[../Immunology/Antihistamines|antihistamine]], and sympathetic α1-blockade effects.
		- <span style="background:rgba(240, 200, 0, 0.2)">Chlorpromazine</span>
		- Thioridazine
	- Stored in fat tissue (lipid soluble) and, therefore, only slowly eliminated from the body.
- <span style="background:rgba(240, 200, 0, 0.2)">Second-generation antipsychotics (also called atypical antipsychotics): most are 5-HT2 and D2 antagonists with varying α and H1 receptor effects</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">Serotonin antagonism can help modulate dopamine, reducing its EPS side effect.</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">Also can improved negative and cognitive symptoms</span>
# First-generation antipsychotics (FGAs)
## High-potency
### Haloperidol
- Brand name: <span style="background:rgba(240, 200, 0, 0.2)">Haldol</span>
- High-potency antipsychotics
	- [[../Neurology/Neurotransmitters|Dopamine]]-specific antagonism (D2 receptor)
- Extrapyramidal symptoms most common in high-potency FGAs
	- <font color="#ffc000">HOLD</font>-ol![[../../assets/img/Pasted image 20240315150139.png|Pasted image 20240315150139.png]]
### Adverse effects
- [[../Endocrine/Hyperprolactinemia|Hyperprolactinemia]] 
	- Dopamine inhibits the release of prolactin via the D2 receptor in the [[../Neurology/Dopaminergic pathway|tuberoinfundibular pathway]]. Therefore, dopamine antagonists increase the effects of prolactin.
- <span style="background:rgba(240, 200, 0, 0.2)">Extrapyramidal symptoms most common in high-potency FGAs</span>
- Prolonged QT interval
- [[./Neuroleptic malignant syndrome|Neuroleptic malignant syndrome]]
## Low-potency
### Chlorpromazine
- Low-potency antipsychotics
	- [[../Neurology/Neurotransmitters|Dopamine]] antagonism
	- Anticholinergic
	- Antihistaminergic
- First discovered, wide range of indications
- Corneal deposits
>[!Mnemonic] 
>氯丙嗪，治精神；阻断多巴Ma不灵。止吐冬眠和降温，就是不治晕动病。不良反应帕金森，张口伸舌坐不能。口干好似阿托品，乳汁分泌羞死人。

>[!Mnemonic] 
><font color="#ffc000">Chlor</font>-neal deposits
### Adverse effects
- Anticholinergic effects, sympatholytic effects, metabolic effects, and <span style="background:rgba(240, 200, 0, 0.2)">sedation dominate</span>
	- Sedation due to histamine receptor blockade, see [[../Immunology/Antihistamines|antihistamine]]

>[!Mnemonic] Difference of Adverse Effects
>Low-potency antipsychotics require higher doses to achieve the desired effect, which leads to more prominent blockage of other receptors except D2.
# Second-generation antipsychotics (SGAs)
## Clozapine
- <span style="background:rgba(240, 200, 0, 0.2)">Most effective antipsychotic</span>
- Indications
	- <span style="background:rgba(240, 200, 0, 0.2)">Treatment-resistant [[./Schizophrenia|schizophrenia]]</span>
	- [[./Schizophrenia|Schizophrenia]] associated with <span style="background:rgba(240, 200, 0, 0.2)">suicidality</span>
- Clozapine can cause agranulocytosis and lowers the seizure threshold
>[!Mnemonic] 
>You must watch <font color="#ffc000">cloz</font>apine <font color="#ffc000">cloz</font>ely to monitor for agranulocytosis!![[../../assets/img/Pasted image 20240315151042.png|Pasted image 20240315151042.png]]
## Olanzapine
- Second effective antipsychotic, without risk of agranulocytosis
- <span style="background:rgba(240, 200, 0, 0.2)">Metabolic effects (usually weight gain</span>, hyperglycemia, new-onset [[../Endocrine/Diabetes mellitus|diabetes mellitus]], dyslipidemia) most prominent
>[!Mnemonic] 
>Olanzapine can make patients <span style="background:rgba(240, 200, 0, 0.2)">gain weight</span>, so it's the pharmacological choice for [[./Anorexia nervosa|Anorexia nervosa]]![[../../assets/img/Pasted image 20240315151300.png|Pasted image 20240315151300.png]]
## Risperidone
- Less sedation, good for elderly patients
>[!Mnemonic] 
><font color="#ffc000">Ris</font>e and shine
## Quetiapine
- More sedation
>[!Mnemonic] 
><font color="#ffc000">Quiet</font>iapine
# Adverse effects
## [[../Endocrine/Hyperprolactinemia|Hyperprolactinemia]]
- <span style="background:rgba(240, 200, 0, 0.2)">Most common in risperidone, amisulpride</span>
>[!Mnemonic] 
><font color="#ffc000">RISE-PAIR</font>-idone gives <font color="#ffc000">RISE</font> to a <font color="#ffc000">PAIR</font>![[../../assets/img/Pasted image 20240315143057.png|Pasted image 20240315143057.png]]
## Extrapyramidal symptoms (EPS)
- Pathophysiology: Inhibition of the nigrostriatal dopaminergic pathways results in EPS.
	- First-generation high-potency antipsychotics: D2antagonism → EPS
	- Second-generation antipsychotics: weaker D2antagonism → fewer EPS
- Clinical features similar to [[../Neurology/Parkinson disease|Parkinson disease]]: Muscle, rustle, and hustle![[../../assets/img/Pasted image 20240317222923.png|Pasted image 20240317222923.png]]
### Tardive dyskinesia
- Repetitive chewing and lip smacking
- Choreic movements
- <span style="background:rgba(240, 200, 0, 0.2)">Can be irreversible if drug is not discontinued</span>
>[!Mnemonic] 
><span style="background:rgba(240, 200, 0, 0.2)">Chewing Tar</span>dive![[../../assets/img/32wab_.gif|32wab_.gif]]